Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PMGC Holdings (ELAB) Cash & Equivalents (2022 - 2025)

PMGC Holdings (ELAB) has disclosed Cash & Equivalents for 4 consecutive years, with $5.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 35.59% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Dec 2025, up 35.59% year-over-year, with the annual reading at $5.4 million for FY2025, 35.59% up from the prior year.
  • Cash & Equivalents hit $5.4 million in Q4 2025 for PMGC Holdings, down from $7.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.6 billion in Q3 2022 to a low of $100034.0 in Q2 2024.
  • Historically, Cash & Equivalents has averaged $115.4 million across 4 years, with a median of $3.7 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: tumbled 99.97% in 2023 and later surged 5580.7% in 2025.
  • Year by year, Cash & Equivalents stood at $1.2 million in 2022, then skyrocketed by 188.06% to $3.3 million in 2023, then rose by 19.77% to $4.0 million in 2024, then surged by 35.59% to $5.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for ELAB at $5.4 million in Q4 2025, $7.7 million in Q3 2025, and $5.7 million in Q2 2025.